Artificial Intelligence across
the early stage value-chain for
Pharmaceutical Research & Drug Discovery
Our mission is to revolutionize early-stage drug discovery and development by democratizing access to cutting-edge generative AI and advanced physics-based simulation technology. Through expert-driven informatics leveraging our highly modular and data-driven in silico platform, we enhance existing workflows, reduce costs and significantly boost success rates
The MedvoltR Advantage
Our AI-accelerated in silico platform - MedGraphR empowers the generation of novel insights through efficient and resource-optimized pipelines. These insights translate into tangible experimental results thus delivering a compelling value proposition
Interpretable & Data-centric AI
We use interpretable models, trained on carefully curated domain data. Our advanced user interface offers real-time visualization of outcomes across the drug discovery pipeline.
Affordable & Enterprise class
Our platform is designed to be affordable, modular, and flexible, catering to the diverse needs of a broad range of clients.
Multi-Domain Expertise
Our formidable team comprises experts spanning bio-physics, chemistry, biology, big data, AI/ML, high-performance computing, and cloud engineering.
Substantial evidence
Our AI predictions effectiveness is enhanced and perfected through rigorous experimental validation.
TECHNOLOGY
Technology towards innovation
Data Ocean
In the realm of translational research, we harness a wealth of diverse data modalities from the biomedical and biochemical fields. Our approach incorporates human-in-the-loop AI technology to curate high-fidelity data. We maintain scalable databases that undergo constant updates to ensure complementarity, uphold data quality, and preserve integrity. These efforts collectively drive the success of complex drug discovery programs.
Drug discovery augmented by AI
We simplify the intricacies of traditional in-silico approaches by harnessing an array of cutting-edge AI techniques, including Generative AI, natural-language processing, transfer learning, and reinforcement learning, among others, within our drug discovery pipeline. These advanced techniques, combined with proprietary data and multi domain expertise, effectively overcome the limitations of traditional methods.
Modular & Scalable Platform
Our modular platform is designed to democratize access to AI-powered in silico technology serving a broad spectrum of clients in the pharmaceutical and biotech industries. Powered by Medvolt's robust cloud infrastructure, we ensure both scalability and top-notch security. Through our user-friendly interface, users can effortlessly create complex in silico workflows, run experiments by provisioning HPC resources and explore results collaboratively with a few clicks.
Knowledge Graph
We curate data from multiple unstructured sources - processing, integrating, and deploying it into an ontology-based knowledge graph representation with sophisticated reasoning capabilities. All of our other data-centric AI modules are built upon the foundation of gold standard data extracted from this curated knowledge base. We combine cutting-edge LLM's with knowledge graphs to continuously build upon our data repositories and drive the generation of focussed insights.
OUR PLATFORM - MedGraphR
Leverage our modules to move beyond serendipity in drug discovery
MedGraph - Rubie
Rubie module stands as a distinctive and versatile drug repurposing platform. Offering two distinct approaches, DRP excels in both the repositioning of drugs and the identification of therapeutic targets for those drugs.
LEARN MORE
MedGraph - Topaaz
Our rapid, enterprise-class platform combines advanced AI and physics-based molecular modeling techniques to expedite the development of novel chemical entities while ensuring a robust toxicology profile.
LEARN MORE
MedGraph EDGE
We swiftly and accurately extract insights from an extensive array of data sources to provide compelling evidence for new predictions in drug discovery.
LEARN MORE
Peptide Therapeutics
We find the best binding, synthesizable, selective peptides with optimal physicochemical and pharmacological properties by meticulously combining cutting-edge in-silico and physics-based modelling methods.
LEARN MOREOUR SOLUTIONS
Discover our comprehensive solutions configured & delivered in a customized way
to meet your specific operational needs
Discover our comprehensive solutions configured & delivered in a customized way to meet your specific operational needs
Data as a Product (DaaP)
Medvolt's data as a service employs cloud architecture to enable clients with safe access to view and analyse varied domain data lakes.
Small Molecule Drug Discovery
Our AI-driven in-silico platform revolutionizes small molecule drug discovery, generating novel compounds with the right pharmacological profile faster and more cost-effectively.
Large Molecule Drug Discovery
With a full-stack AI-powered platform, we explore even the uncharted chemical space to find potentially safe large molecules as therapies for a wide range of diseases.
NEWS & MEDIA COVERAGE
Explore the latest news and milestones as Medvolt transforms the future of drug discovery
Join Us at AI Driven Drug Discovery Summit 2024
Date: 12-14 November, 2024
Location: Boston, United States
Schedule a meeting with our team to discuss your R&D needs and explore our innovative solutions and offerings in AI-driven drug discovery.
SUBSCRIBE TO OUR NEWSLETTER
Get the latest updates & insights on biotech news, plus exclusive updates from us!
